SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Merck -- Ignore unavailable to you. Want to Upgrade?


To: Rob L. who wrote (1084)12/9/1998 4:33:00 PM
From: Anthony Wong  Respond to of 1580
 
Rob, read Merck's news release as well. Merck confirmed that NDA for Vioxx was submitted to FDA on Nov. 23, almost 6 months behind Celebrex even if Vioxx is accorded priority review status, which hasn't been announced today. Profit taking all around, as Merck has ran up a lot recently.